For Researchers

Combining academic forces

iDNA has an extensive community of researchers, experts, and key opinion leaders involved in lung cancer screening. This community provides a network that drives the implementation and innovation of lung cancer screening worldwide. iDNA’s community focuses on lung cancer, coronary heart disease (CHD), and chronic obstructive pulmonary disease (COPD), together referred to as the ‘Big 3’ diseases.

We are constantly building new R&D projects to expand the body of knowledge of the Big 3cdiseases. iDNA can partner in your research, and you can also contact us for research opportunities in our ongoing projects and trials. If you want to participate in our research or join our community, please contact us with the form at the bottom of this page. These are a few of our current partners:

iDNA Faculty Members

iDNA works together with key opinion leaders in the field of lung cancer screening

Prof. J.K. Field, PhD

Chair iDNA Faculty

Professor John K. Field

Professor John Field, PhD, FRCPath has a Personal Clinical Chair in Molecular Oncology at the University of Liverpool.  He is a Visiting Professor at University College London, holds the post of Director of Research of the Roy Castle Lung Cancer Research Programme. 

He is the Chief Investigator for the UK Lung Cancer Screening Trial (UKLS). Previous Chair of the IASLC Screening Prevention & Early Detection Committee and he formed IASLC Strategic Screening Advisory Group. Member of ILCCO and served on the Steering Committee. 

He was presented with the IASLC Joseph Cullen Award at the WCLC 2011, in recognition of lifetime scientific achievements in lung cancer prevention research. He is Co-Chair of the IASLC Strategic Screening Advisory Committee and Co-lead on the IASLC Early Lung Cancer Imaging Confederation (ELIC) project.

He is the principle investigator of the Liverpool Lung Project, a molecular- epidemiological study into the early detection of lung cancer (~14,000 recruited), funded by the Roy Castle Lung Cancer Foundation. The UKLS and the LLP form part of the NCRI Lung Cancer portfolio. A Partner in the FP7 CURELUNG and LCAOS projects and co-applicant on the recently funded NIH U19 programme grant; also contributed to the lung cancer genetic susceptibility ‘Lung Oncoarray’ project. He is also heavily involved in the identification of molecular diagnostic markers in lung and head & neck cancers. His research funding has been provided mainly by the RCF, NWCRF, MRC, CRUK, EU, NIH and the HTA.  

Professor Field is the author of over 320 international (peer reviewed) papers in his area of expertise with an h index of 67 and has given more than 350 presentations at medical and scientific conferences around the world.

Prof. M. Oudkerk, MD PhD

Vice-chair of iDNA Faculty

Professor Matthijs Oudkerk

Prof. Oudkerk is responsible for the Research & Development of iDNA.

Many of the current and new guidelines in CT screening for lung cancer and cardiovascular diseases are derived from his original work.  His vision on the future of imaging and health care, has been recognized with many international awards and invitations to lecture on (inter-)national platforms.

With an H-Index (times a researcher is cited) of 70, prof. Oudkerk is a true leading expert in the field of early detection of lung cancer and cardiovascular diseases. As Principal Investigator of the NELSON study he paved the way for implementation of lung cancer screening in Europe.

Prof. Oudkerk is Radiologist by training and did his medical training in Leiden, the Netherlands. He has been professor in Radiology for more than 20 years and published more than 550 scientific articles.

Professor Alexander M.M. Eggermont

Prof. Eggermont is Chief Scientific Officer of the Princess Máxima Center for Pediatric Oncology, the Netherlands. He is a full Professor of Oncology Classe Exceptionnelle, Paris-Sud University, Paris, France and coordinator of the Comprehensive Cancer Center Program Deutsche KrebsHilfe, Germany. He is also strategic advisor at DKFZ-NCT for the Multisite NCT program in Germany.

He previsouly held the post of Director General at the Gustave Roussy Comprehensive Cancer Center in Villejuif, France, (2010-2020) and was a full Professor of Surgical Oncology (2003-2016) and Endowed Professor of International Networking in Cancer Research (2011-2018) at the Erasmus University MC Rotterdam.

Professor Eggermont is a surgeon in oncology by training and has over 900 publications to his name and an h-index of 101 (Scopus).

Professor Shi-Yuan Liu

Professor Shi-Yuan LIU, MD, chief physician, doctoral mentor, is the chairman of the radiology department in Changzheng Hospital affiliated to the Second Military Medical University (SMMU).With more than 30-year experience, he was enrolled in the Shanghai Leading Talent and Excellent Discipline Leaders Plan and Shanghai 21st Century Talents Plan.

Prof. Liu is good at thoracic radiology, especially on lung cancer imaging diagnosis. He mainly focuses on early stage lung cancer screening, imaging diagnosis, differential diagnosis and comprehensive interventional therapy for late stage lung cancer; pulmonary opportunistic infection; functional imaging of COPD; molecular imaging and artificial intelligence in medical imaging. Prof. Liu is in charge of 23 research projects with a total fund of more than 25 million RMB granted from national key research and development program of China, national natural science foundation of China, and so on. As the first or corresponding author, more than 310 academic articles were published, including 69 SCI papers, such as Radiology, Chest, and European Radiology. He is the winner of many honors and academic awards, such as the Second Prize of Military Science and Technology Progress, and the First Prize of Shanghai Science and Technology Progress. Four patents were authorized. 11 books were published as the chief or associate editor, such as the Practical thoracic imaging diagnosis, body MRI, and so on.

His academic positions include: elected chairman of Chinese Society of Radiology, the President of the Chinese Medical Imaging AI Innovation Alliance and he leads the national efforts of AI research and applications in radiology. He is the chairman of the China Medical Equipment Association CT committee, vice president of Chinese Association of Radiologists, vice president of Radiological section of China Health Care International Association for the promotion of international exchange, Chairman of Shanghai Society of Radiology and Chairman of Shanghai Radiological Society of Biomedical Engineering. He also is chief or associate editor in more than 10 journals, including the Chinese Journal of Radiology and the Journal of Clinical Radiology.

Dirkjan Kuijpers, MD, PhD, EBCR

Dirkjan Kuijpers (MD, PhD, EBCR) is a senior cardiovascular radiologist. He received his medical training at the University of Leiden, The Netherlands. After staff memberships at Leiden University Medical Center (1985) and the Daniel den Hoed Kliniek in Rotterdam (1994-1998), he became head of the department of Radiology at the Bronovo Hospital in The Hague.

In 2005 he received his PhD on Cardiac Dobutamine Stress MRI at the University Medical Center Groningen. For his work on cardiac MRI he was awarded in 2003 at the ESCR in Berlin and in 2004 at the ECR in Vienna. In 2004 he was awarded the “Haagse Specialisten Prijs” for his innovating work on dobutamine stress MRI. He is (co-) author of over 50 scientific articles and one of the authors of the international guidelines on the assessment of acute myocardial infarction (2011) and myocardial ischemia (2018) issued by the North American Society of Cardiovascular Imaging (NASCI) and the European Society of Cardiac Radiology (ESCR).

From 2012 to 2019 he was acknowledged as scientific Principle Investigator and Lecturer at Center for Medical Imaging North East Netherlands (CMI-nen). He participated as chief investigator in several national and international randomized controlled trials. Since 2015 he is head of the cardiovascular department of Radiology at the HMC (Haaglanden Medical Center) in The Hague.

Our Projects

iDNA and the Erasmus MC (NL) are organising the European lung cancer screening trial: 4-IN-THE-LUNG-RUN (4ITLR). The goal of the study is to evaluate personalised strategies in recruitment, screening intervals, smoking cessation and other co-morbidity (coronary heart disease and COPD) preventing strategies.


Research partners from the Erasmus MC

Professor Harry de Koning, MD PhD

  • Principal Ivestigator of the European 4-IN-THE-LUNG-RUN trial
  • Professor of Public Health & screening evaluation at the Department of Public Health at Erasmus MC

Carlijn van der Aalst, PhD

  • Coordinator 4-IN-THE-LUNG-RUN and ROBINSCA
  • Senior research fellow for the department of Public Health at the Erasmus MC

Kevin ten Haaf, PhD

  • Modeller/statistician for Erasmus MC
  • Member of Cancer Intervention and Screening Network (CISNET) group and NELSON research group

Jeanine Roeters van Lennep, MD PhD

  • Internist vascular medicine at Erasmus MC
  • Board member of the Dutch Society of Gender and Health and currently leads the ACE (Academic Centre of Excellence) GESTURE

Research partners from the University of Nottingham

Professor David R. Baldwin, MD, FRCP

  • Consultant respiratory physician and honorary professor of medicine at the Nottingham University Hospitals
  • Lead respiratory physician on the UKLS study, chair of the lung Cancer Clinical Reference Group for NHS England (National Lead)

Rachael L. Murray, PhD

  • Associate Professor of Health Policy at the University of Nottingham/UK Centre for Tobacco and Alcohol Studies
  • Currently working with the European Alliance for Personalised Medicine and the American Thoracic Society Clinical Practice Guideline working group on guidance and guidelines

Dr. Manpreet Bains, PhD

  • Assistant professor in Qualitative and Mixed Methods Health Research at the University of Nottingham
  • Jointly coordinates the UK Centre for Tobacco and Alcohol Studies’ (UKCTAS) tobacco-related public involvement activity

Professor Sarah A. Lewis, PhD

  • Professor of Medical Statistics at the University of Nottingham
  • currently on the Cancer Research UK Tobacco Advisory Group funding panel

Professor Richard Hubbard, MD, FRCP

  • Professor of Respiratory Epidemiology at the University of Nottingham since 2006
  • Academic lead for the UK National Lung Cancer Audit since 2015

Research partners from the German Cancer Research Centre

Professor Rudolf Kaaks, PhD

  • Professor (Chair, Cancer Epidemiology) at the University of Heidelberg
  • Head of the Division of Cancer Epidemiology at the German Cancer Research Center (DKFZ), Heidelberg, Germany

Professor Stefan Delorne, MD

  • Co-PI of the ongoing German Lung Cancer Screening trial (LUSI)
  • Chairman of the German Committee on Radiation Protection in Medicine

Research partners from the Catalan Institute of Oncology

Professor Josep Alfons Espinàs, MD PhD

  • Professor of the Master of Public Health UPF-UAB
  • Coordinator of the Office of Cancer Screening

Josep M. Borràs, MD PhD

  • Director and CEO of the Comprehensive Cancer Centre
  • Director of the Catalonian Cancer Control Plan

Ernest Nadal, MD PhD

  • Oncologist and lead of the Clinical Research group in Solid Tumours (CReST) within the IDIBELL

Belen del Rio, MD PhD

  • Radiologist in the Chest Radiology Department at Bellvitge University Hospital

Professor Susana Padrones, MD PhD

  • Pulmonologist at Bellvitge University Hospital
  • Coordinator of the Lung Function Unit

Research partners from the University College London Hospitals

Professor dr. Sam Janes, MD PhD

  • Head of UCL Respiratory
  • Member of several scientific and granting committees including CRUK, British Thoracic Oncology Group and the NICE interventional procedures panel

Research partners from the National Cancer Institute of Milan

Ugo Pastorino, MD

  • Director of the Thoracic Surgery Division at the Istituto Nazionale Tumori of Milan since 2003
  • Presently responsible of three prospective trials on lung cancer screening with LDCT and circulating biomarkers

Research partners from Gustave Roussy Cancer Campus

Dr. Corinne Balleyguier, MD PhD

  • Head of medical imaging department and head of diagnostic imaging unit at Gustave Roussy
  • Senior radiologist at Gustave Roussy

Research partners from the Essen University Hospital and University Clinic

Professor Clemens Aigner, MD, MBA

  • Professor of Thoracic Surgery and at University Medicine Essen – Ruhrlandklinik
  • Head of the Department of Thoracic Surgery and Surgical Endoscopy at University Medicine Essen – Ruhrlandklinik

Professor dr. Michael Forsting

  • Director of the Institute of Diagnostic and Interventional Radiology and Neuroradiology at Essen University Hospital

Professor Martin Schuler, MD PhD

  • Professor of oncology at the Department of Medical Oncology, University Clinic Essen

Professor Christian Taube

  • Professor of pulmonology at the Ruhrlandklinik

Felix Nensa, MD PhD

  • Radiologist at the University Hospital Essen

Contact us here if you have any questions: